Search Results - "Saf Eldin, Linda"

Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men by Hannawi, Suad, Saf Eldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Hassan, Aala, Xu, Shuping, Li, Jian, Liu, Dongfang, Baidoo, Adam Abdul Hakeem, Ibrahim, Dima, Alhaj, Mojtaba, Chen, Yuanxin, Zhou, Qiang, Xie, Liangzhi

“…The safety and immunogenicity of a protein-based tetravalent vaccine SCTV01E that contains spike protein ectodomain (S-ECD) of Alpha, Beta, Delta and Omicron…”
Get full text

Author Correction: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men by Hannawi, Suad, Saf Eldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Hassan, Aala, Xu, Shuping, Li, Jian, Liu, Dongfang, Baidoo, Adam Abdul Hakeem, Ibrahim, Dima, Alhaj, Mojtaba, Chen, Yuanxin, Zhou, Qiang, Xie, Liangzhi

Get full text

Immunogenicity and Safety of Omicron-Containing Multivalent COVID-19 Vaccines in Unvaccinated and Previously Vaccinated Adults by Hannawi, Suad, Abuquta, Alaa, Eldin, Linda Saf, Hassan, Aala, Alamadi, Ahmad, Gao, Cuige, Baidoo, Adam Abdul Hakeem, Yang, Xinjie, Su, Huo, Zhang, Jinxiu, Xie, Liangzhi

“…The SARS-CoV-2 evolution trajectory remains uncertain, and the antigenic characteristics of future variants are highly unpredictable. We report the…”
Get full text

Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C in adults previously vaccinated with inactivated vaccine: A randomized, double-blind, placebo-controlled phase 1/2 clinical trial by Hannawi, Suad, Saifeldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Li, Jian, Chen, Yuanxin, Xie, Liangzhi

Get full text

Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1/2 clinical trial by Hannawi, Suad, Saifeldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Hassan, Aala, Liu, Dongfang, Yan, Lixin, Xie, Liangzhi

“…Booster vaccination is an efficient way to address the waning protection of vaccines and immune escape of SARS-CoV-2 variants. We aimed to assess the safety…”
Get full text

Safety and immunogenicity of multivalent SARS-CoV-2 protein vaccines: a randomized phase 3 trial by Hannawi, Suad, Yan, Lixin, Saf Eldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Hassan, Aala, Zhang, Miaomiao, Gao, Cuige, Chen, Yuanxin, Gai, Wenlin, Xie, Liangzhi

“…COVID-19 vaccines that offer broad-spectrum protection are needed. We aimed to evaluate the safety and immunogenicity of multivalent vaccines, SCTV01E and…”
Get full text